Fundraising Fox

Quotient Therapeutics

1 known investors

quotient-tx.com ↗

Quotient Therapeutics is a biotechnology company applying somatic genomics — the study of genetic variation within the trillions of cells in the body — to identify genes causally linked to disease and develop new medicines. It focuses on turning genetically-validated targets into therapeutics across a range of diseases.

AI & Machine LearningBiotech

Investors · 1

Flagship PioneeringCambridge · $500K – $10M

In the news

Top Biotech VC Firms 2026: Leading Biotech Startup Investors Guidequbit.capital · Apr 2026Quotient Therapeutics Raises $25M to Unlock a New Universe of Genetic Variation for Transformational Medicinesleadsontrees.com · May 2025Flagship launches Quotient Therapeutics, its first UK startupcen.acs.org · Nov 2023Quotient Therapeutics secured US$50,000,000 in a remarkable growth funding round.startupmag.co.uk · Nov 2023Quotient Therapeutics Raises $50M in Initial Fundingfinsmes.com · Nov 2023

Frequently asked questions

What does Quotient Therapeutics do?
Quotient Therapeutics is a biotechnology company applying somatic genomics — the study of genetic variation within the trillions of cells in the body — to identify genes causally linked to disease and develop new medicines. It focuses on turning genetically-validated targets into therapeutics across a range of diseases.
Who are Quotient Therapeutics's investors?
Quotient Therapeutics's investors include Flagship Pioneering.